Form 4: Jazz Pharmaceuticals Executive Awarded Restricted Stock Units

Patricia Carr, SVP and Chief Accounting Officer of Jazz Pharmaceuticals, received 2,987 restricted stock units on March 1, 2024, under the company's 2011 Equity Incentive Plan.

Summary

• Patricia Carr, the SVP and Chief Accounting Officer of Jazz Pharmaceuticals, was granted 2,987 restricted stock units on March 1, 2024.
• These units were awarded under the Issuer's 2011 Equity Incentive Plan.
• Each restricted stock unit represents a contingent right to receive one ordinary share upon vesting.
• The units vest in equal annual installments over four years, starting from the vesting commencement date of March 5, 2024.
• Specifically, 1/4th of the units will vest on the first anniversary of March 5, 2024, and the remaining units will vest in equal annual installments over the subsequent three years.
• Following the transaction, Ms. Carr beneficially owns 10,300 ordinary shares.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.

Positives

• The grant of restricted stock units aligns Ms. Carr's interests with those of the shareholders, incentivizing her to contribute to the company's long-term success.
• The vesting schedule encourages continued service and commitment from Ms. Carr over the next four years.

Future Outlook

The vesting of the restricted stock units over the next four years suggests an expectation of continued service and contribution from Ms. Carr.

Industry Context

Grants of restricted stock units are a common practice in the pharmaceutical industry to incentivize and retain key executives.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in the pharmaceutical industry, often benchmarked against peer companies of similar size and market capitalization.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize equity-based compensation to align executive interests with shareholder value.

Stakeholder Impact

• The grant of restricted stock units aligns executive interests with shareholder value, potentially leading to increased long-term performance.
• Employees may view this as a positive sign of investment in leadership and the company's future.

Key Dates